AKBA: Akebia Therapeutics, Inc. Stock

by  •  • Comments Off on AKBA: Akebia Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 2,082.70
Enterprise Value ($M) 2,157.29
Book Value ($M) 24.58
Book Value / Share 0.09
Price / Book 84.73
NCAV ($M) -81.82
NCAV / Share -0.31
Price / NCAV -25.45

Profitability (mra)
Return on Invested Capital (ROIC) -0.21
Return on Assets (ROA) -0.20
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 2.02
Current Ratio 2.23

Balance Sheet (mrq) ($M)
Current Assets 203.78
Assets 310.19
Liabilities 285.60
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 160.18
Operating Income -46.21
Net Income -69.41
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -40.66
Cash from Investing -0.03
Cash from Financing 49.66

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-30 13G Vanguard Group Inc 5.37 66.75
04-17 13G/A BlackRock, Inc. 6.10 -0.36
02-14 13G/A Satter Muneer A 2.60 -64.53

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2025-03-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-06-06 3,089,834 7,806,964 39.58
2025-06-05 1,988,519 5,302,100 37.50
2025-06-04 3,726,006 9,866,511 37.76
2025-06-03 2,796,431 6,883,784 40.62
2025-06-02 2,825,290 7,517,222 37.58

(click for more detail)

Similar Companies
AGEN – Agenus Inc. AIMD – Ainos, Inc.
AKAN – Akanda Corp. ALDX – Aldeyra Therapeutics, Inc.
ALGS – Aligos Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io